Those of us dealing w/recurrent ear infections may have an alternative to the cost of Augmentin as this generic is approved:

Ranbaxy OK'D on Generic Augmentin
Source: United Press International
Publication date: 2007-01-31

Indian firm Ranbaxy said it has been approved to market a generic version of GlaxoSmithKline's Augmentin.
The company said the U.S. Food and Drug Administration approved its amoxicillin and clavulanate potassium for oral suspension, 600 mg/42.9 mg (base)/5 mL.

Ranbaxy estimated combined sales of Augmentin Oral Suspension at $216 million, with sales of the 600 mg/42.9 mg/5 mL formulation totaling $136.9 million in the suspension market, quoting data from IMS Health.

The drug is indicated for the treatment of pediatric patients with recurrent or persistent acute otitis media due to S. pneumoniae, H. influenzae or M. catarrhalis.

__________________
Make someone's heart smile today.

Funny you should bring this up, I just filled an Augementin scrip w/a generic (at least it was at my generic copay) this past Sat.